loadpatents
name:-0.015799999237061
name:-0.0047369003295898
name:-0.0008690357208252
Nugiel; David Patent Filings

Nugiel; David

Patent Applications and Registrations

Patent applications and USPTO patent grants for Nugiel; David.The latest application filed is for "ethanamine compounds and methods of using the same".

Company Profile
0.4.10
  • Nugiel; David - Cherry Hill NJ
  • Nugiel; David - Wilmington DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Ethanamine compounds and methods of using the same
Grant 9,035,065 - Balestra , et al. May 19, 2
2015-05-19
4-quinolinemethanols as anti-malarial agents
Grant 8,716,265 - McElroy , et al. May 6, 2
2014-05-06
Ethanamine Compounds And Methods Of Using The Same
App 20130137731 - Balestra; Michael ;   et al.
2013-05-30
Ethanamine Compounds and Methods of Using the Same
App 20120277272 - Balestra; Michael ;   et al.
2012-11-01
Ethanamine Compounds and Methods of Using the Same
App 20120115913 - Balestra; Michael ;   et al.
2012-05-10
Ethanamine compounds and methods of using the same 545
Grant 8,013,165 - Balestra , et al. September 6, 2
2011-09-06
Ethanamine Compounds and Methods of Using the Same 545
App 20100179199 - Balestra; Michael ;   et al.
2010-07-15
Bicyclic Benzimidazole Compounds and Their Use as Metabotropic Glutamate Receptor Potentiators
App 20090192169 - Egle; Ian ;   et al.
2009-07-30
Chroman Compounds
App 20090170851 - Bernstein; Peter ;   et al.
2009-07-02
Pyrazolone Compounds As Metabotropic Glutamate Receptor Agonists For The Treatment Of Neurological And Psychiatric Disorders
App 20090069340 - Balestra; Michael ;   et al.
2009-03-12
Chroman compounds
App 20070185107 - Bernstein; Peter ;   et al.
2007-08-09
Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents
App 20040048844 - Nugiel, David ;   et al.
2004-03-11
Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents
App 20030073686 - Nugiel, David ;   et al.
2003-04-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed